Concepedia

Publication | Closed Access

Characterization of Wild-Type Recombinant Bet v 1a as a Candidate Vaccine against Birch Pollen Allergy

46

Citations

34

References

2005

Year

Abstract

On the basis of these structural and biological properties, rBet v 1a is a valid candidate vaccine against birch pollen allergy, currently evaluated in humans.

References

YearCitations

Page 1